# DEFB106B

## Overview
DEFB106B is a gene that encodes the protein defensin beta 106B, a member of the beta-defensin family, which is integral to the innate immune system. Defensin beta 106B is a small, cationic peptide known for its antimicrobial properties, particularly in epithelial cells, where it serves as a first line of defense against a wide range of pathogens, including bacteria, fungi, and viruses (Mookherjee2020Antimicrobial; Semple2003Duplication). The protein is characterized by a structure rich in cysteine residues, which form disulfide bonds essential for its stability and function. Predominantly expressed in the testes, DEFB106B is thought to play a specific role in the immune defense of the male reproductive tract (Semple2003Duplication). Beyond its antimicrobial activity, defensin beta 106B may also contribute to immune modulation by acting as a chemotactic agent for immune cells, thereby linking innate and adaptive immune responses (Semple2003Duplication).

## Structure
DEFB106B, a beta-defensin, is characterized by a primary structure rich in cysteine residues, which are crucial for forming disulfide bonds. These bonds are essential for the protein's stability and function. The secondary structure of DEFB106B is predominantly composed of beta-sheets, a common feature among defensins, which contributes to its structural integrity and biological activity. The tertiary structure of DEFB106B involves a compact and stable fold, typical of defensins, allowing it to effectively participate in the immune response. While quaternary structure is less common in defensins, DEFB106B may undergo post-translational modifications such as glycosylation or proteolytic processing, which can influence its activity and stability. These modifications are important for the protein's maturation and function within the immune system. The presence of conserved cysteine residues and the resulting disulfide bonds are critical for maintaining the protein's structural conformation and ensuring its role in host defense mechanisms.

## Function
DEFB106B encodes a beta-defensin protein that is part of the defensin family, which plays a crucial role in the innate immune response. These proteins are small cationic peptides with antimicrobial activity, primarily active in epithelial cells, and are involved in the first line of defense against a variety of pathogens, including bacteria, fungi, and viruses (Mookherjee2020Antimicrobial; Semple2003Duplication). 

The DEFB106 gene, along with other β-defensins, is predominantly expressed in the testes, suggesting a specific role in the innate defense mechanism of the male reproductive tract (Semple2003Duplication). The mature peptides encoded by DEFB106 and related genes have undergone rapid divergence, likely due to positive selection, which has altered the charge of amino-acid residues. This selection is thought to be a response to pathogen evolution, enhancing the protein's ability to disrupt microbial membranes and protect against infections (Semple2003Duplication).

In addition to their antimicrobial properties, β-defensins, including those encoded by DEFB106B, may have roles in linking innate and adaptive immune responses. They can be chemotactic for dendritic cells and T cells, acting on dendritic cells via Toll-like receptor 4, thus contributing to immune modulation (Semple2003Duplication).

## Clinical Significance
Mutations in the DEFB106B gene or alterations in its expression levels have been associated with various immune system disorders. These changes can lead to an increased susceptibility to infections due to the gene's role in antimicrobial activity. The defensin family, to which DEFB106B belongs, is crucial for the innate immune response, and any disruption in its function can compromise the body's ability to fend off pathogens. Inflammatory diseases have also been linked to alterations in DEFB106B expression, suggesting that the gene plays a role in regulating inflammation. Understanding these alterations provides valuable insights into the mechanisms underlying these conditions and highlights potential therapeutic targets for treatment. The study of DEFB106B and its interactions is essential for developing strategies to manage and treat diseases associated with immune dysfunction.


## References


[1. (Mookherjee2020Antimicrobial) Neeloffer Mookherjee, Marilyn A. Anderson, Henk P. Haagsman, and Donald J. Davidson. Antimicrobial host defence peptides: functions and clinical potential. Nature Reviews Drug Discovery, 19(5):311–332, February 2020. URL: http://dx.doi.org/10.1038/s41573-019-0058-8, doi:10.1038/s41573-019-0058-8. This article has 822 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41573-019-0058-8)

[2. (Semple2003Duplication) Colin AM Semple, Mark Rolfe, and Julia R Dorin. Duplication and selection in the evolution of primate β-defensin genes. Genome Biology, April 2003. URL: http://dx.doi.org/10.1186/gb-2003-4-5-r31, doi:10.1186/gb-2003-4-5-r31. This article has 123 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2003-4-5-r31)